about
Reverse Genetics Approaches for the Development of Influenza VaccinesSupplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferretsCharacterisation of a wild-type influenza (A/H1N1) virus strain as an experimental challenge agent in humansMucosal vaccination with recombinant Lactobacillus casei-displayed CTA1-conjugated consensus matrix protein-2 (sM2) induces broad protection against divergent influenza subtypes in BALB/c mice.MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell responseTraditional and new influenza vaccinesProtection of Chinese painted quails (Coturnix chinensis) against a highly pathogenic H5N1 avian influenza virus strain after vaccination.Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.Nanofilaments on glioblastoma exosomes revealed by peak force microscopy.A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2.Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice.Influenza reverse genetics: dissecting immunity and pathogenesis.A clinical approach to the threat of emerging influenza viruses in the Asia-Pacific region.In Silico Analysis of HA2/Mx Chimera Peptide for Developing an Adjuvanted Vaccine to Induce Immune Responses Against Influenza Viruses.A dual purpose universal influenza vaccine candidate confers protective immunity against anthrax.Mission of randomness.
P2860
Q28076140-C83F98A0-DE02-4750-AD4D-D5873861DFBFQ28602586-A1E160D3-CF0C-43ED-84D9-DEBAC8583116Q35066015-612A010E-BBE6-41E9-B424-92AF3B847F0DQ35142923-15A8490A-4D59-4981-B672-1EA9860CC81BQ36381178-F48877A1-F68D-4479-8900-5AF43B54FEECQ37035833-503F2919-72C3-4916-95A7-562CDEB52E56Q37316060-BCE3A999-D0BE-4FDC-A9DE-54A81C985B70Q37469592-D9A821A0-CFD0-4604-8E60-55DA586750D1Q37507833-F76A9961-F96B-4F8A-B466-C597111D1898Q37547653-7F1AB614-13E4-4EBD-88FD-9DC59952F434Q37582869-0A387B89-9190-494F-893E-6946066B10D9Q38188084-0950B583-C11C-42CD-B7A1-28A25E942EF4Q39414987-31776AB3-D48A-47D3-BE89-10ADF624AFF1Q40079652-F82937C9-7AD5-4AF2-94B4-DCC9B9AD36DCQ40489092-F8DC0377-7602-4480-88F0-E023AC794EE9Q42524635-13488CFA-63C1-4F80-B639-2225AFC0E2E3
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Novel vaccines against influenza viruses.
@ast
Novel vaccines against influenza viruses.
@en
type
label
Novel vaccines against influenza viruses.
@ast
Novel vaccines against influenza viruses.
@en
prefLabel
Novel vaccines against influenza viruses.
@ast
Novel vaccines against influenza viruses.
@en
P2860
P1433
P1476
Novel vaccines against influenza viruses
@en
P2093
P2860
P356
10.1016/J.VIRUSRES.2011.09.037
P577
2011-10-01T00:00:00Z